Prior Treatment Time Affects Survival Outcomes in Metastatic Breast Cancer

PURPOSE: Sequential drug treatments in metastatic breast cancer (MBC) are disparate. Clinical trial data includes limited reporting of treatment context, primarily including the number of prior therapies. This study evaluates the relationship between prior treatment time, prior lines of treatment, a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JCO Clin Cancer Inform
Hauptverfasser: Rocque, Gabrielle B., Gilbert, Aidan, Williams, Courtney P., Kenzik, Kelly M., Nakhmani, Arie, Kandhare, Pravinkumar G., Bhatia, Smita, Burkard, Mark E., Azuero, Andres
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2020
Schlagworte:
Original Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7444642/
https://ncbi.nlm.nih.gov/pubmed/32479187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/CCI.20.00008
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge